|
| Tuesday, February 17, 2015 |
|
|
Omnicare Declares Quarterly Cash Dividend |
| Omnicare, Inc. (NYSE:OCR), today announced that its Board of Directors has approved a quarterly cash dividend of $0.22 per share on the Company's common stock, to be paid on March 27, 2015, to all stockholders of record on March 12, 2015. more info >> |
|
| Friday, February 6, 2015 |
|
|
ACS, Part of the Omnicare Specialty Care Group, to Provide Specialty Pharmacy Services for IBRANCE(R) (palbociclib) |
| Advanced Care Scripts (ACS), a leading specialty pharmacy platform of Omnicare Specialty Care Group (SCG), announced today that they have been selected as a specialty pharmacy authorized to dispense Pfizer's Ibrance(R) (palbociclib). more info >> |
|
| Thursday, January 22, 2015 |
|
|
Omnicare to Report Fourth-Quarter and Year-End 2014 Financial Results and Hold Conference Call on Wednesday, February 25, 2015 |
| Omnicare, Inc. (NYSE:OCR) will release its financial results for the fourth-quarter and full-year 2014, before the market opens on Wednesday, February 25, 2015. more info >> |
|
| Saturday, January 10, 2015 |
|
|
Omnicare Announces Conversion Rate Adjustment for Convertible Debentures; Series A and Series B Trust PIERS to Accrue Contingent Interest |
| Omnicare, Inc. (NYSE: OCR) (the "Company") announced today an adjustment to the conversion rate of its 3.25% Convertible Senior Debentures due 2035 and its 3.25% Convertible Senior Exchange Debentures due 2035 (collectively, the "2035 Debentures"). more info >> |
|
| Tuesday, January 6, 2015 |
|
|
Omnicare to Present at the J.P. Morgan Healthcare Conference |
| Omnicare, Inc. (NYSE:OCR) today announced that it will present at the 33rd Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2015 at 2:00 p.m. PST (5:00 p.m. EST) in San Francisco, California. more info >> |
|
| Saturday, December 6, 2014 |
|
|
Omnicare Announces 10% Increase in Quarterly Cash Dividend |
| Omnicare, Inc. (NYSE:OCR), today announced an increase to its quarterly dividend, demonstrating the Company's continued focus on returning value to its stockholders. more info >> |
|
| Wednesday, November 12, 2014 |
|
|
Omnicare Announces Conversion Rate Adjustment for Convertible Notes |
| Omnicare, Inc. (NYSE: OCR) (the "Company") announced today an adjustment to the conversion rate of its 3.75% Convertible Senior Subordinated Notes due 2042 (the "2042 Notes"). more info >> |
|
| Friday, November 7, 2014 |
|
|
Omnicare Announces Pricing of Senior Notes Offering |
| Omnicare, Inc. (NYSE: OCR) announced today that it has priced its public offering of $400 million aggregate principal amount of 4.75% Senior Notes due 2022 at 100% of principal amount, and $300 million aggregate principal amount of 5.00% Senior Notes due 2024 at 100% of principal amount. more info >> |
|
|
Omnicare to Present at the Credit Suisse 2014 Health Care Conference |
| Omnicare, Inc. (NYSE:OCR) today announced that it will present at the Credit Suisse Health Care Conference on Tuesday, November 11, 2014 at 3:30 p.m. MST (5:30 p.m. ET) in Phoenix, Arizona. more info >> |
|
| Thursday, November 6, 2014 |
|
|
Omnicare Announces Public Offering of Senior Notes |
| Omnicare, Inc. (NYSE: OCR) (the "Company") announced today that it plans to offer $700 million aggregate principal amount of senior notes due 2022 and senior notes due 2024 in an underwritten public offering. more info >> |
|
|
|
|
